Provider review
CLYR Health review
Its own "$199/mo" label doesn't match its own billing math.
CLYR Health's own tirzepatide page labels its refill "$199/mo" but the same page discloses the actual charge is "$398 billed once" per 8-week cycle — roughly $216/mo averaged over the true billing period, about 8.6% more than advertised — and its own homepage states three different, unreconciled numbers for state coverage ("most states," "47 States," "all 50 states") in three different sections.
Transparency scorecard
2 of 4 disclosed openly
What CLYR Health discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Disclosed
Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
CLYR Health's own pages state: tirzepatide "$149 first month" then "$199/mo on 8-week cycles" (actually "$398 billed once" per cycle); semaglutide "$169/month" flat; sermorelin "from $109/mo."
What you actually pay, month to month
Tirzepatide's own page discloses the "$199/mo" refill is actually billed as "$398 billed once" per 8-week (56-day) cycle — roughly $216/mo averaged over the true period. Semaglutide is a flat $169/mo with no qualifier found. Sermorelin's "from $109/mo" is a hedged floor, not independently confirmed at typical dosing.
The commitment trap
Tirzepatide's "$199/mo" refill label doesn't match its own billing mechanics — the actual charge is "$398 billed once" per 8-week cycle, about 8.6% more than the advertised monthly figure once averaged over the true period.
Checked live on CLYR Health's own site at https://www.clyr.health/tirzepatide in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off CLYR Health's own public pages on the date shown, not from a third-party comparison table.
The bottom line
CLYR Health (clyr.health) is a real, live telehealth company selling compounded tirzepatide, compounded semaglutide, and sermorelin, naming a specific fulfillment pharmacy (The Pharmacy Hub, Miami, FL) directly with an unhedged "503A Licensed Pharmacy" claim. Two real, independent findings keep this off the trust tier: a refill price label that doesn't match its own stated billing mechanics, and a three-way self-contradiction on which states it actually serves.
CLYR Health appears on our sermorelin provider ranking, our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want a specific fulfillment pharmacy named by name and address, with a direct 503A claim.
- You want all three of this site's tracked compounds from one company.
- You're comfortable independently confirming your own state's coverage before signing up, given the site's own three conflicting claims.
Look elsewhere if
- You're budgeting around the "$199/mo" tirzepatide label — the same page's own billing mechanics show the real charge is closer to $216/mo, averaged over its true 8-week cycle.
- You need a firm answer on whether your state is covered — the site states "most states," "47 states," and "all 50 states" in three different places, none reconciled.
- You want a refund if you change your mind — its own Terms state, "All fees are non-refundable due to the nature of the services and products provided."
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what CLYR Health bundles in, and what it does not.
Clinician consult
Included
— a clinician evaluation is required before a prescription is issued, per its own site.
Bloodwork / labs
Not stated on the pages checked.
Follow-ups and dose changes
Not itemized on the pages checked.
Human support
No dietitian, nurse, or structured coaching program is named…
anywhere on the pages checked.
Injection supplies
Not itemized beyond the medication itself on the pages checked.
Shipping
Not itemized on the pages checked.
Who fills it, and who's watching
The pharmacy
503A. Its own Terms of Service name a specific pharmacy by name and address, "The Pharmacy Hub, 15600 NW 15th Ave, Suite C, Miami, FL 33169," and separately state "503A Licensed Pharmacy."
Oversight
Included — a clinician evaluation is required before a prescription is issued, per its own site. Not itemized on the pages checked.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
Not published as a single figure — its own homepage states three different, unreconciled numbers in three different sections: the nav says "Ships to most states," a trust-badge row (repeated three times) says "Ships to 47 States," and its own FAQ says "Our services are available in all 50 states."
The honest cons
The part they would rather you skipped
Two independent findings, both from CLYR Health's own site: (1) its own tirzepatide page labels the refill "$199/mo," but the same page discloses the actual charge is "$398 billed once" per "8-Week cycle" (2 vials) — roughly $216/mo averaged over the true 56-day billing period, about 8.6% more than advertised; (2) its own homepage states three different, unreconciled numbers for state coverage in three different sections — "most states," "47 States," and "all 50 states" — none of which is reconciled anywhere on the site.
- Its own "$199/mo" tirzepatide refill label doesn't match its own billing mechanics — the real charge averages closer to $216/mo over its true 8-week cycle.
- Its own homepage states three different, unreconciled numbers for state coverage.
- Its own Terms state all fees are non-refundable.
None of this is unique to CLYR Health — the whole category shares it.
How it compares
The providers we rank on our sermorelin provider ranking — the most specific board CLYR Health sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- TRTelos RxA specific, sourced state-exclusion list — next to an unconfirmed "compare" price.
- Strut HealthAn FDA warning letter over labeling, plus an auto-refill price on every product.
- MAMangoRxA flat, "price locked in" semaglutide product — its pharmacy is described, not named.
- SRSynergy RxSells no GLP-1 at all — and its own legal terms undercut its "all 50 states" marketing.
- EHEOS HealthNames five 503A pharmacies — but its own legal pages disagree on HIPAA.
- PLPlexusDxPriciest starting-price seller; the only one admitting it's not FDA-approved.
- PRPreventiveMDShows every price tier in one table — but its own headline is the cheapest one.
- ZHZera HealthNames its pharmacy directly — but issues no refund except medical disqualification.
38 more providers rank on our sermorelin provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect CLYR Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on CLYR Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.